These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16865091)
1. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091 [TBL] [Abstract][Full Text] [Related]
2. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice. Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597 [TBL] [Abstract][Full Text] [Related]
3. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice. Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503 [TBL] [Abstract][Full Text] [Related]
5. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442 [TBL] [Abstract][Full Text] [Related]
6. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862 [TBL] [Abstract][Full Text] [Related]
7. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191 [TBL] [Abstract][Full Text] [Related]
8. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice. Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515 [TBL] [Abstract][Full Text] [Related]
9. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury. Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633 [TBL] [Abstract][Full Text] [Related]
10. 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. Couturier JY; Ding-Zhou L; Croci N; Plotkine M; Margaill I Exp Neurol; 2003 Dec; 184(2):973-80. PubMed ID: 14769390 [TBL] [Abstract][Full Text] [Related]
11. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion. Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia. Greco R; Tassorelli C; Mangione AS; Levandis G; Certo M; Nappi G; Bagetta G; Blandini F; Amantea D Eur J Pharmacol; 2014 Dec; 744():91-7. PubMed ID: 25446913 [TBL] [Abstract][Full Text] [Related]
13. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model. Jiao Y; Li G Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817 [TBL] [Abstract][Full Text] [Related]
14. [Researched of PJ34 which is protective effect on the glutamate-induced HT-22 cell damage]. Fan HB; Wang YN; Geng DQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):712-3. PubMed ID: 20862804 [TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. Berti R; Williams AJ; Moffett JR; Hale SL; Velarde LC; Elliott PJ; Yao C; Dave JR; Tortella FC J Cereb Blood Flow Metab; 2002 Sep; 22(9):1068-79. PubMed ID: 12218412 [TBL] [Abstract][Full Text] [Related]
17. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice. Ahmad SF; Zoheir KM; Ansari MA; Korashy HM; Bakheet SA; Ashour AE; Al-Shabanah OA; Al-harbi MM; Attia SM Mol Immunol; 2015 Feb; 63(2):394-405. PubMed ID: 25304310 [TBL] [Abstract][Full Text] [Related]
18. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia. Zhu Y; Saito K; Murakami Y; Asano M; Iwakura Y; Seishima M Neurosci Lett; 2006 Jan; 393(2-3):122-6. PubMed ID: 16356636 [TBL] [Abstract][Full Text] [Related]
19. [Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats]. Feng CS; Ma HC; Yue Y; Zhang YQ; Qu XD Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2110-4. PubMed ID: 15730629 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]